Literature DB >> 12740490

Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?

Ahmet Tefekli1, Tarik Esen, Orhan Ziylan, Bülent Erol, Abdullah Armagan, Haluk Ander, Mustafa Akinci.   

Abstract

OBJECTIVES: Urolithiasis in children is recognized with an increasing frequency, while exact etiological factors remain to be determined. The aim of this study is to compare the metabolic risk factors and saturation of urine in pediatric and adult calcium oxalate (Ca-Ox) stone formers.
METHODS: A total of 33 pediatric (mean age: 6.8 +/- 3.1 years) and 120 adult patients (mean age: 39.7 +/- 5.7 years), with documented Ca-Ox urinary stone disease, underwent a comprehensive metabolic evaluation at our institution. Beside a broad serum analysis, concentrations of calcium, oxalate, magnesium, uric acid and citrate were measured in 24-hour collected urine. Saturation of urine was calculated by Marshall-Robertson's nomograms.
RESULTS: Hypocitraturia, observed in 60.6%, and hypomagnesuria, detected in 39.4%, but not hypercalciuria, were the most common metabolic risk factors in the pediatric group. In adults, hypercalciuria still represented one of the major metabolic risk factors, detected in 44.1%, although hypocitraturia, observed in 45.8%, was the most prevalent metabolic risk factor, as it was in the pediatric group. Pediatric cases had significantly (p < 0.05) higher prevalence of hypocitraturia, hypomagnesuria and supersaturated urine when compared to adults. Metabolic abnormalities could be detected in a high percentage (82%) of primary and recurrent pediatric Ca-Ox stone formers, but not in primary adult stone formers.
CONCLUSIONS: Metabolic risk factors significantly differ in pediatric and adult Ca-Ox stone formers. Hypocitraturia and hypomagnesuria seem to play a major role in stone formation, and metabolic abnormalities can be detected in a significant percentage of both primary and recurrent pediatric stone formers. Thus, a comprehensive metabolic evaluation is of utmost importance for all children with Ca-Ox stones. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740490     DOI: 10.1159/000070134

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  23 in total

Review 1.  Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment.

Authors:  K Sarica
Journal:  Urol Res       Date:  2006-01-24

2.  Metabolic risk factors in children with asymptomatic hematuria.

Authors:  Francisco Rodolfo Spivacow; Elisa Elena Del Valle; Paula Gabriela Rey
Journal:  Pediatr Nephrol       Date:  2016-02-25       Impact factor: 3.714

3.  Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study.

Authors:  Vidar O Edvardsson; Solborg E Ingvarsdottir; Runolfur Palsson; Olafur S Indridason
Journal:  Pediatr Nephrol       Date:  2018-04-06       Impact factor: 3.714

4.  Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density.

Authors:  Gudmar Thorleifsson; Hilma Holm; Vidar Edvardsson; G Bragi Walters; Unnur Styrkarsdottir; Daniel F Gudbjartsson; Patrick Sulem; Bjarni V Halldorsson; Femmie de Vegt; Frank C H d'Ancona; Martin den Heijer; Leifur Franzson; Claus Christiansen; Peter Alexandersen; Thorunn Rafnar; Kristleifur Kristjansson; Gunnar Sigurdsson; Lambertus A Kiemeney; Magnus Bodvarsson; Olafur S Indridason; Runolfur Palsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

5.  Results of medical treatment and metabolic risk factors in children with urolithiasis.

Authors:  Metin Kaya Gürgöze; Mehmet Yusuf Sarı
Journal:  Pediatr Nephrol       Date:  2011-02-22       Impact factor: 3.714

6.  Urinary stone risk factors in the descendants of patients with kidney stone disease.

Authors:  Thasinas Dissayabutra; Nuttiya Kalpongkul; Jakkhaphan Rattanaphan; Chanchai Boonla; Monpicha Srisa-Art; Wattanachai Ungjaroenwathana; Piyaratana Tosukhowong
Journal:  Pediatr Nephrol       Date:  2018-03-28       Impact factor: 3.714

7.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

8.  Demographic characteristics and metabolic risk factors in Croatian children with urolithiasis.

Authors:  Danko Milošević; Danica Batinić; Daniel Turudić; Danko Batinić; Marija Topalović-Grković; Ivan Pavao Gradiški
Journal:  Eur J Pediatr       Date:  2013-10-06       Impact factor: 3.183

9.  Metabolic risk factors and the effect of metaphylaxis in pediatric stone disease with hypocitraturia.

Authors:  Onur Karsli; Volkan Izol; I Atilla Aridogan; Ali Borekoglu; Nihat Satar
Journal:  Urolithiasis       Date:  2012-12-30       Impact factor: 3.436

10.  Urolithiasis in the first year of life.

Authors:  Ayfer Gür Güven; Mustafa Koyun; Yunus Emre Baysal; Sema Akman; Emel Alimoglu; Halide Akbas; Adnan Kabaalioglu
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.